Literature DB >> 7609777

Characteristics of binding of [3H]NE-100, a novel sigma-receptor ligand, to guinea-pig brain membranes.

M Tanaka1, T Shirasaki, S Kaku, M Muramatsu, S Otomo.   

Abstract

We examined the characteristics of binding of radiolabeled N,N-dipropyl-2-[4-methoxy-3-(2-phenyl-ethoxy)phenyl]- ethylamine monohydrochloride ([3H] NE-100), a highly potent and selective sigma-receptor ligand, to guinea-pig brain membranes. [3H]NE-100 showed saturable and reversible binding to sigma binding sites. A dissociation constant (Kd) and maximal numbers of binding sites (Bmax) obtained from Scatchard plot analysis were 1.2 +/- 0.1 nM and 1049.3 +/- 115.1 fmol/mg protein (n = 3), respectively. NE-100 was the most potent inhibitor of [3H]NE-100 binding among several structurally dissimilar sigma-receptor ligands, including haloperidol and (+)-pentazocine. (+)-Benzomorphanes had more than a 10-fold potent inhibitory activity over (-)-benzomorphanes, with regard to [3H]NE-100 binding. The binding of [3H]NE-100 was not influenced by histaminergic, dopaminergic, adrenergic, serotonergic cholinergic or glutaminergic agents at 10(-7) M. GTP-gamma-S and phenytoin also did not affect the binding of [3H]NE-100. A higher [3H]NE-100 binding was observed in the cerebellum and medulla oblongata. Except for the nuclear fraction, the highest level of [3H]NE-100 binding to subcellular fractions was observed in microsomal fractions. These results suggest that NE-100 selectively binds, with a high affinity, to sigma-1 binding sites in guinea-pig brain membranes, as an "antagonist".

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7609777     DOI: 10.1007/BF00233243

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  36 in total

Review 1.  Sigma receptors: biology and function.

Authors:  J M Walker; W D Bowen; F O Walker; R R Matsumoto; B De Costa; K C Rice
Journal:  Pharmacol Rev       Date:  1990-12       Impact factor: 25.468

2.  The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog.

Authors:  W R Martin; C G Eades; J A Thompson; R E Huppler; P E Gilbert
Journal:  J Pharmacol Exp Ther       Date:  1976-06       Impact factor: 4.030

3.  Sigma opioid receptor: characterization and co-identity with the phencyclidine receptor.

Authors:  L G Mendelsohn; V Kalra; B G Johnson; G A Kerchner
Journal:  J Pharmacol Exp Ther       Date:  1985-06       Impact factor: 4.030

4.  Phencyclidine and sigma opiate receptors in brain: biochemical and autoradiographical differentiation.

Authors:  A L Gundlach; B L Largent; S H Snyder
Journal:  Eur J Pharmacol       Date:  1985-07-31       Impact factor: 4.432

5.  Autoradiographic localization of sigma receptor binding sites in guinea pig and rat central nervous system with (+)3H-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine.

Authors:  A L Gundlach; B L Largent; S H Snyder
Journal:  J Neurosci       Date:  1986-06       Impact factor: 6.167

6.  Haloperidol-sensitive (+)[3H]SKF-10,047 binding sites (sigma sites) exhibit a unique distribution in rat brain subcellular fractions.

Authors:  D J McCann; T P Su
Journal:  Eur J Pharmacol       Date:  1990-04-25       Impact factor: 4.432

7.  Heterogeneous binding of sigma radioligands in the rat brain and liver: possible relationship to subforms of cytochrome P-450.

Authors:  S B Ross
Journal:  Pharmacol Toxicol       Date:  1991-04

8.  High-affinity dextromethorphan binding sites in guinea pig brain. II. Competition experiments.

Authors:  G L Craviso; J M Musacchio
Journal:  Mol Pharmacol       Date:  1983-05       Impact factor: 4.436

9.  H1 antihistamines interact with central sigma receptors.

Authors:  N M Gray; P C Contreras; S E Allen; D P Taylor
Journal:  Life Sci       Date:  1990       Impact factor: 5.037

10.  High-affinity dextromethorphan binding sites in guinea pig brain. I. Initial characterization.

Authors:  G L Craviso; J M Musacchio
Journal:  Mol Pharmacol       Date:  1983-05       Impact factor: 4.436

View more
  5 in total

1.  Antiproliferative and cytotoxic effects of some sigma2 agonists and sigma1 antagonists in tumour cell lines.

Authors:  Nicola Antonio Colabufo; Francesco Berardi; Marialessandra Contino; Mauro Niso; Carmen Abate; Roberto Perrone; Vincenzo Tortorella
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-07-31       Impact factor: 3.000

2.  Selective reduction of alcohol drinking in Sardinian alcohol-preferring rats by a sigma-1 receptor antagonist.

Authors:  Valentina Sabino; Pietro Cottone; Yu Zhao; Luca Steardo; George F Koob; Eric P Zorrilla
Journal:  Psychopharmacology (Berl)       Date:  2009-05-14       Impact factor: 4.530

Review 3.  Sigmar1's Molecular, Cellular, and Biological Functions in Regulating Cellular Pathophysiology.

Authors:  Richa Aishwarya; Chowdhury S Abdullah; Mahboob Morshed; Naznin Sultana Remex; Md Shenuarin Bhuiyan
Journal:  Front Physiol       Date:  2021-07-07       Impact factor: 4.566

Review 4.  Small-Molecule Modulators of Sigma1 and Sigma2/TMEM97 in the Context of Cancer: Foundational Concepts and Emerging Themes.

Authors:  Halley M Oyer; Christina M Sanders; Felix J Kim
Journal:  Front Pharmacol       Date:  2019-10-21       Impact factor: 5.810

5.  Sigma non-opioid receptor 1 is a potential therapeutic target for long QT syndrome.

Authors:  LouJin Song; Ramsey Bekdash; Kumi Morikawa; Jose R Quejada; Alison D Klein; Danielle Aina-Badejo; Kazushige Yoshida; Hannah E Yamamoto; Amy Chalan; Risako Yang; Achchhe Patel; Dario Sirabella; Teresa M Lee; Leroy C Joseph; Fuun Kawano; Junco S Warren; Rajesh K Soni; John P Morrow; Masayuki Yazawa
Journal:  Nat Cardiovasc Res       Date:  2022-02-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.